Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Does the dopamine transporter protein allele predict growth hormone testing results or response to growth hormone therapy?

Endocrine - 1 Apr 2010

Daniel Maala, Mastrandrea Lucy D, Salis Robbert J, Erbe Richard, Quattrin Teresa

Abstract excerpt

Animal studies have shown dopamine transporter protein (DAT1) knock out mice are growth retarded and hyperactive. DAT1 has been researched in several human psychiatric studies with varying results regarding phenotype and DAT1 alleles. However, the relationship between DAT1 and short stature in humans has not been explored. Buccal swabs were collected from patients receiving growth hormone (GH) therapy and were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Alleles
Share to Body Height

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dopamine Plasma Membrane Transport Proteins

Share to Growth Disorders

Share to Human Growth Hormone

Share to Predictive Value of Tests

Source

Identifiers

PMID: 20960275
DOI: 10.1007/s12020-010-9313-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Does the dopamine transporter protein allele predict growth hormone testing results or response to growth hormone therapy?PMID 20960275Read ↗

The Growth Response to Growth Hormone (GH) Treatment in Children with Isolated GH Deficiency Is Independent of the Presence of the Exon 3-Minus Isoform of the GH ReceptorSemantic proximity Read ↗

The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age.Semantic proximity Read ↗

Growth hormone-binding protein in short children.Semantic proximity Read ↗

The growth hormone receptor (GHR) polymorphism in growth-retarded children with Cushing disease: lack of association with growth and measures of the somatotropic axis.Semantic proximity Read ↗

Impact of polymorphisms of human beta-adrenergic receptor gene on changes in height during growth hormone treatment.Semantic proximity Read ↗

Shortening L-DOPA testing time in the diagnosis of growth hormone deficiency: is it possible?Semantic proximity Read ↗

Growth hormone dose in growth hormone-deficient adults is not associated with IGF-1 gene polymorphisms.Semantic proximity Read ↗

Allelic variations of the D2 dopamine receptor gene in children with idiopathic short stature.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.